We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Rapid Lateral Flow Assay Detects Several Viral Fevers Simultaneously

By LabMedica International staff writers
Posted on 10 Mar 2015
A team of biomedical engineers has developed a rapid diagnostic test that is able to detect several viruses such as Ebola, dengue fever, and yellow fever simultaneously from a single sample of patient's serum.

Investigators at the Massachusetts Institute of Technology (Cambridge, MA, USA) and Harvard Medical School (Boston, MA, USA) used a novel class of silver nanoparticles to drive a paper-based lateral flow assay. More...
Lateral flow assays are commonly used to detect such pathogens as Rotavirus, adenovirus, Streptococcus A and B, and gonorrhea and in rapid pregnancy tests.

The investigators extended the usefulness of the lateral flow approach by incorporating antibodies bound to different colored nanoparticles. In the current version of the assay, following a 10 minute incubation, an orange band indicates the presence of yellow fever virus, a red band indicates Ebolavirus, and a green band indicates dengue fever virus.

The investigators expect that their new rapid test will complement more definitive diagnostic technologies, such as PCR. "If you are in a situation in the field with no power and no special technologies, if you want to know if a patient has Ebola, this test can tell you very quickly that you might not want to put that patient in a waiting room with other people who might not be infected," said senior author Dr. Lee Gehrke, professor of microbiology and immunology at Harvard Medical School. "That initial triage can be very important from a public health standpoint, and there could be a follow-up test later with PCR or something to confirm."

This type of diagnostic testing device is readily customizable to detect other infectious diseases, by linking the silver nanoparticles to different antibodies. "Thankfully the Ebola outbreak is dying off, which is a good thing, but what we are thinking about is what is coming next," said Dr. Gehrke. "There will undoubtedly be other viral outbreaks. It might be Sudan virus, or it might be another hemorrhagic fever. What we are trying to do is develop the antibodies needed to be ready for the next outbreak that is going to happen."

The rapid diagnostic test for multiple viral fevers was described in the February 12, 2015, online edition of the journal Lab on a Chip.

Related Links:
Massachusetts Institute of Technology
Harvard Medical School



New
Gold Member
Thyroid-Stimulating Hormone Test
ULTRA-TSH
New
Gold Member
Latex Test
SLE-Latex Test
New
Calprotectin Test
CALiaGold
New
Nutating Mixer
Enduro MiniMix
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The POC device rapidly predicts neonatal respiratory disease at birth in the NICU (Photo courtesy of SIME Diagnostics)

AI-Powered Lung Maturity Test Identifies Newborns at Higher Risk of Respiratory Distress

Each year, approximately 300,000 babies in the United States are born between 32 and 36 weeks' gestation, according to national health data. This group is at an elevated risk for respiratory distress,... Read more

Molecular Diagnostics

view channel
Image: The new study findings emphasize the need for incorporating disease heterogeneity into type 2 diabetes care strategies (Photo courtesy of Cell 2025; doi.org/10.1016/j.cell.2025.05.00)

Molecular Fingerprint for Insulin Sensitivity Could Diagnose Diabetes Before Disease Develops

Insulin is a hormone essential for regulating blood sugar levels, and its dysfunction is a key factor in the development of diabetes. Insulin resistance, a condition where the body's cells do not respond... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: Custom hardware and software for the real-time detection of immune cell biophysical signatures in NICU (Photo courtesy of Pediatric Research, DOI:10.1038/s41390-025-03952-y)

First-Of-Its-Kind Device Profiles Newborns' Immune Function Using Single Blood Drop

Premature infants are highly susceptible to severe and life-threatening conditions, such as sepsis and necrotizing enterocolitis (NEC). Newborn sepsis, which is a bloodstream infection occurring in the... Read more

Pathology

view channel
Image: Results of AI-based 3D virtual H&E staining and quantitative analysis of pathological tissue (Photo courtesy of Nature Communications, DOI:10.1038/s41467-025-59820-0)

Virtual Staining Technology Paves Way for Non-Invasive Pathological Diagnosis

For more than 200 years, traditional pathology has depended on the technique of examining cancer tissues under a microscope, a method that provides only limited, specific cross-sections of the 3D structure... Read more

Technology

view channel
Image: Concept of biosensor integrated into hygiene pads enabling direct semi-quantitative analysis of biomarkers in unprocessed menstruation blood (Photo courtesy of Dosnon, L et al. DOI: 10.1002/advs.202505170)

First Ever Technology Recognizes Disease Biomarkers Directly in Menstrual Blood in Sanitary Towels

Over 1.8 billion people menstruate worldwide, yet menstrual blood has been largely overlooked in medical practice. This blood contains hundreds of proteins, many of which correlate with their concentration... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.